Financial Data (Consolidated)
*Fiscal years run from Apr. 1 to Mar. 31 of the following year.
FY | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net Sales (Millions of yen) |
3,525,799 | 3,917,434 | 4,402,823 | 4,909,557 | 4,896,104 |
Operating Income (Millions of yen) |
145,332 | 182,011 | 57,942 | 143,396 | 202,941 |
Pre-tax profit (Millions of yen) |
167,523 | 219,983 | 73,741 | 149,877 | 173,440 |
Profit attributable to owners of parent (Millions of yen) |
105,638 | 141,941 | 37,670 | 90,813 | 107,586 |
Earnings per share (yen) |
89.28 | 391.96 | 139.77 | 336.93 | 137.81 |
Total Assets (Millions of yen) |
4,027,103 | 4,205,801 | 4,135,826 | 4,643,016 | 4,284,600 |
Shareholders' Equity (Millions of yen) |
1,758,609 | 1,996,508 | 1,991,437 | 2,402,029 | 2,233,265 |
Book-value per Share (yen) |
1,899.10 | 2,172.45 | 2,165.95 | 2,641.39 | 2,609.69 |
Capital Adequacy Ratio (%) |
38.1% | 41.8% | 42.3% | 46.0% | 46.1% |
Return on Equity (ROE) (%) |
7.5% | 8.6% | 2.1% | 4.7% | 5.2% |
Return on Assets (ROA) (%) |
2.6% | 3.4% | 0.9% | 2.1% | 2.4% |
Capital Expenditures (Millions of yen) |
190,268 | 218,771 | 221,494 | 230,033 | 223,738 |
Depreciation & Amortization (Millions of yen) |
240,016 | 245,257 | 263,562 | 259,831 | 257,434 |
R & D Expenses (Millions of yen) |
189,850 | 194,162 | 218,631 | 225,594 | 236,844 |
- Note:Net Sales does not include the sles tax.
- Note:On October 1, 2024, the Company conducted a three-for-one stock split for its common stock.
"Basic earnings per share" and "Equity attributable to owners of the parent per share" are calculated assuming the stock split had been conducted at the beginning of the fiscal year ending March 2021.
Revenue/Overseas Revenue Ratio

Operating Profit/Revenue Operating Profit Margin

Sales by Region


Revenue Breakdown by Product (FY2025)

